Meijuan Li

Meijuan Li

Company: Eisai

Job title: Vice President, Head of Biostatistics, Oncology Group

Seminars:

Driver Mutation Variant Allele Frequency (VAF) in Circulating Tumor DNA and Association with Clinical Outcome in NSCLC Patients with EGFR- and KRAS-Mutated Tumors 10:40 am

• Is ctDNA a good potential surrogate endpoint for survival time? • How can we implement ctDNA testing in trials in terms of surrogate endpoint monitoring?Read more

day: day 2 red

Chair’s Closing Remarks & Close of the 12th World Clinical Biomarkers & CDx Summit 2022 6:15 pm

Read more

day: Day 2 Afternoon

Collectively Progressing Precision Medicine

Track Chair: 3:51 pm

Read more

day: Day 2 Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.